Send the following on WhatsApp
Continue to ChatApollomics, Inc. announces successful enrollment of first patient in a phase 1 clinical trial of APL-106 (Uproleselan Injection) in China https://israelnational.news/apollomics-inc-announces-successful-enrollment-of-first-patient-in-a-phase-1-clinical-trial-of-apl-106-uproleselan-injection-in-china.html